SHOCK: Australia declares Fluoride "completely safe"
(Natural News) The debate over water fluoridation goes back decades to when communities began fluoridating water to prevent tooth decay. Over the years multiple studies have shown that while it may improve oral health, it comes with many health-damaging side-effects such as reduced IQ, cancer, attention deficit hyperactivity disorder (ADHD), obesity, and depression. Ignoring the... (Source: NaturalNews.com)
Source: NaturalNews.com - July 14, 2017 Category: Consumer Health News Source Type: news

Keith Conners, Psychologist Who Set Standard for Diagnosing A.D.H.D., Dies at 84
After devising a scale for treating attention deficit hyperactivity disorder, Dr. Conners later expressed dismay over how loosely the label was being applied. (Source: NYT Health)
Source: NYT Health - July 14, 2017 Category: Consumer Health News Authors: BENEDICT CAREY Tags: Conners, Keith Deaths (Obituaries) Attention Deficit Hyperactivity Disorder Psychology and Psychologists Children and Childhood Source Type: news

ADHD medication tied to lower risk for alcohol, drug abuse in teens and adults
(Indiana University) The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study published in the American Journal of Psychiatry and led by Indiana University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2017 Category: International Medicine & Public Health Source Type: news

ADHD in Teens
Attention Deficit Hyperactivity Disorder (ADHD) in Teens (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 11, 2017 Category: General Medicine Source Type: news

Medications Boost Academic Performance in ADHD Patients Medications Boost Academic Performance in ADHD Patients
Individuals with attention-deficit/hyperactivity disorder (ADHD) often have problems with academic achievement, but new research suggests that medication can improve their performance.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - July 7, 2017 Category: Psychiatry Tags: Psychiatry News Source Type: news

Borderline personality and attention-deficit hyperactivity traits in childhood are associated with hypomanic features in early adulthood - Mistry S, Zammit S, Price VE, Jones HJ, Smith DJ.
BACKGROUND: There is limited understanding of the symptomatic development of bipolar disorder from childhood to early adulthood. AIMS: We assessed whether borderline personality disorder traits, ADHD, and emotional, behavioural and social difficulties duri... (Source: SafetyLit)
Source: SafetyLit - July 1, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Mydayis for the Treatment of Attention Deficit Hyperactivity Disorder
Mydayis is a CNS stimulant drug indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 13 years and above. (Source: Drug Development Technology)
Source: Drug Development Technology - June 30, 2017 Category: Pharmaceuticals Source Type: news

Methylphenidate disintegration from oral formulations for intravenous use by experienced substance users - Bjarnadottir GD, Johannsson M, Magnusson A, Rafnar BO, Sigurdsson E, Steingrimsson S, Asgrimsson V, Snorradottir I, Bragadottir H, Haraldsson HM.
BACKGROUND AND AIMS: Methylphenidate (MPH) is a prescription stimulant used to treat attention-deficit hyperactivity disorder. MPH is currently the preferred substance among most intravenous (i.v.) substance users in Iceland. Four types of MPH preparations... (Source: SafetyLit)
Source: SafetyLit - June 28, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Neurocognitive characteristics of youth with noncomorbid and comorbid forms of conduct disorder and attention deficit hyperactivity disorder - Glenn AL, Remmel RJ, Ong MY, Lim NSJ, Ang RP, Threadgill AH, Ryerson N, Raine A, Fung D, Ooi YP.
OBJECTIVE: Studies investigating neurocognitive deficits in youth with conduct disorder (CD) and attention deficit hyperactivity disorder (ADHD) are often confounded by the high rates of comorbidity between the two. METHOD: Neurocognitive functioni... (Source: SafetyLit)
Source: SafetyLit - June 28, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Psychosocial stress and brain function in adolescent psychopathology - Quinlan EB, Cattrell A, Jia T, Artiges E, Banaschewski T, Barker G, Bokde ALW, Bromberg U, B üchel C, Brühl R, Conrod PJ, Desrivieres S, Flor H, Frouin V, Gallinat J, Garavan H, Gowland P, Heinz A, Martinot JL, Paillère Martinot ML, Nees F, Papadopoulos-Orfanos D, Paus T, Poustka L, Smolka MN, Vetter NC, Walter H, Whelan R, Glennon JC, Buitelaar JK, Happé F, Loth E, Barker ED, Schumann G.
OBJECTIVE: The authors sought to explore how conduct, hyperactivity/inattention, and emotional symptoms are associated with neural reactivity to social-emotional stimuli, and the extent to which psychosocial stress modulates these relationships. ME... (Source: SafetyLit)
Source: SafetyLit - June 23, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Childhood ADD or ADHD (Attention Deficit Hyperactivity Disorder in Children)
Title: Childhood ADD or ADHD (Attention Deficit Hyperactivity Disorder in Children)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/23/2017 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - June 23, 2017 Category: Pediatrics Source Type: news

Shire receives FDA approval for Mydayis to treat attention deficit hyperactivity disorder
Biotechnology company Shire has received the US Food and Drug Administration (FDA) approval for Mydayis (mixed salts of a single-entity amphetamine product) for the treatment of attention deficit hyperactivity disorder (ADHD). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - June 22, 2017 Category: Pharmaceuticals Source Type: news

Rare genetic variants found to increase risk for Tourette syndrome
An international team led by researchers from UCLA and Massachusetts General Hospital has identified the first definitive genes associated with Tourette syndrome, giving scientists a long-sought foothold on the biology of the disease.The report in the June 21 issue of Neuron describes the discovery of rare mutations — either deletions or duplications of genetic material — in two neurodevelopmental genes, NRXN1 and CNTN6, in people with Tourette syndrome, a disorder characterized by multiple chronic, involuntary motor and vocal tics.“This is a first, key step in understanding the role of these genes in the...
Source: UCLA Newsroom: Health Sciences - June 21, 2017 Category: Universities & Medical Training Source Type: news

Shire's long-acting ADHD drug wins U.S. approval
(Reuters) - The U.S. Food and Drug Administration (FDA) on Tuesday approved Shire Plc's long-acting therapy for attention deficit hyperactivity disorder (ADHD), adding another treatment to its stock of drugs for the cognitive condition that affects millions of children. (Source: Reuters: Health)
Source: Reuters: Health - June 21, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

QuickStats: Percentage of Children and Teens Aged 4 –17 Years Ever Diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD), by Sex and Urbanization of County of Residence — National Health Interview Survey, 2013–2015
(Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - June 15, 2017 Category: American Health Source Type: news

Parental ADHD symptoms and parenting behaviors: a meta-analytic review - Park JL, Hudec KL, Johnston C.
Attention-deficit/hyperactivity disorder (ADHD) persists throughout the lifespan, and there are known impairments associated with adult ADHD. Understanding ADHD-related impairments in the parenting domain is particularly important given that the children o... (Source: SafetyLit)
Source: SafetyLit - June 15, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Motor vehicle crash risk among adolescents and young adults with attention-deficit/hyperactivity disorder - Curry AE, Metzger KB, Pfeiffer MR, Elliott MR, Winston FK, Power TJ.
IMPORTANCE: Attention-deficit/hyperactivity disorder (ADHD) often persists into adolescence, when motor vehicle crash risk peaks. We know little about when adolescents with ADHD get licensed and, once they do, the extent to which they have increased crash ... (Source: SafetyLit)
Source: SafetyLit - June 15, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

ADHD tied to driver's license delays, crash risks
(Reuters Health) - Adolescents with attention deficit hyperactivity disorder (ADHD) may wait longer than other teens to obtain a driver's license, and they may be at higher risk for accidents once they do start driving, suggests a new study. (Source: Reuters: Health)
Source: Reuters: Health - June 12, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Young drivers with ADHD 36% more likely to have an accident, study says
Adolescents with attention deficit hyperactivity disorder are 36% more likely than other adolescent drivers to get into a car accident, according to a study published Monday in JAMA Pediatrics. (Source: CNN.com - Health)
Source: CNN.com - Health - June 12, 2017 Category: Consumer Health News Source Type: news

Teens with ADHD Face a Higher Crash Risk
Study found they were 36 percent more likely to get in an accident than other adolescentsSource: HealthDay Related MedlinePlus Pages: Attention Deficit Hyperactivity Disorder, Motor Vehicle Safety, Teen Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - June 12, 2017 Category: Consumer Health News Source Type: news

Teens With ADHD Face a Higher Crash Risk
MONDAY, June 12, 2017 -- As if parents don't worry enough when their teens drive the family car, new research shows that adolescents with attention-deficit/hyperactivity disorder (ADHD) are even more likely than their peers to have an accident. On a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 12, 2017 Category: General Medicine Source Type: news

Do Antidepressants in Pregnancy Raise Kids ’ ADHD Risk? Do Antidepressants in Pregnancy Raise Kids ’ ADHD Risk?
Women with depression may be more likely than other mothers to have children with attention-deficit/hyperactivity disorder (ADHD) even if they don ’ t take antidepressants during pregnancy, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 8, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Do antidepressants in pregnancy raise kids ’ ADHD risk?
(Reuters Health) - Women with depression may be more likely than other mothers to have children with attention-deficit/hyperactivity disorder (ADHD) even if they don ’t take antidepressants during pregnancy, a recent study suggests. (Source: Reuters: Health)
Source: Reuters: Health - June 7, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

When Does Hoarding Become A Problem, And How Can We Help Alleviate It?
By Carol R. Hevia, PsyD Hoarding is a mental health disorder characterized by a persistent and powerful difficulty in getting rid of collected items, regardless of their value. Left untreated, this behavior can lead to a variety of damaging emotional, social, financial, and physical effects—for both the hoarder and their family members. It is also important to distinguish between hoarding and collecting. Collectors are proud of their collections and enjoy displaying them. Hoarders, on the other hand, are ashamed. Reasons Why People Hoard Hoarding, like most mental health behaviors, is complex. Researchers initially t...
Source: Healthy Living - The Huffington Post - June 7, 2017 Category: Consumer Health News Source Type: news

University professors now abusing ADHD drugs just like their students
(Natural News) Like their students, one in five university professors are seemingly hooked on using medications for attention-deficit hyperactivity disorder (ADHD) to keep up with the demands of their jobs, Cambridge University academic and neuroscientist Dr. Hannah Critchlow discussed at The Hay Festival. According to Dr. Critchlow, an increasing number of university professors were found to use these... (Source: NaturalNews.com)
Source: NaturalNews.com - June 6, 2017 Category: Consumer Health News Source Type: news

How Do I Keep My Prescription Stimulant Safe At College?
Discussion Going away to college presents new and exciting opportunities for young adults. It also is an important time for transitioning many adult responsibilities to the young adult too. Keeping safe is important and safety tips for college can be reviewed here. Any medication can be abused. Prescription stimulants are no different. Normally prescription stimulants are used for treatment of attention deficit disorder, narcolepsy and treatment resistant depression. They can help increase alertness, attention, and energy, cognition, learning and memory. However for these reasons and because they are easy to obtain and r...
Source: PediatricEducation.org - June 5, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Racial and ethnic differences in ADHD treatment quality among Medicaid-enrolled youth - Cummings JR, Ji X, Allen L, Lally C, Druss BG.
OBJECTIVES: We estimated racial/ethnic differences in attention-deficit/hyperactivity disorder (ADHD) care quality and treatment continuity among Medicaid-enrolled children. METHODS: Using Medicaid data from 9 states (2008 to 2011), we identified 1... (Source: SafetyLit)
Source: SafetyLit - June 3, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Cingulate moves controlled-release ADHD drug to human testing
Cingulate Therapeutics said this week that it began a proof-of-concept trial for its controlled-release attention deficit/hyperactivity disorder drug. The 4-week clinical trial is being conducted by its development partner, Bio-Images Drug Delivery. The trial enrolled healthy volunteers to evaluate the pharmacokinetic behavior of CTX-1301, including the body’s absorption, distribution, metabolism and excretion of the drug. The drug uses multi-core, timed-release technology to last the entire active day and minimize the patient’s “crashing” feeling in the afternoon, according to the company. Get the ...
Source: Mass Device - June 2, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Neurological Pharmaceuticals bioimagesdrugdelivery cingulatetherapeutics Source Type: news

Kids' ADHD Risk May Be Linked to Mother's Underlying Mental Health, Not Prenatal Antidepressant Use (FREE)
By Kelly Young Edited by Andr é Sofair, MD, MPH Prenatal antidepressant use is associated with increased risk for attention-deficit/hyperactivity disorder in offspring, but the elevated risk might not be caused by the drugs, suggests a study in The … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - June 2, 2017 Category: Primary Care Source Type: news

Attention deficit/hyperactivity disorder and risk of injuries: a systematic review and meta-analysis - Amiri S, Sadeghi-Bazargani H, Nazari S, Ranjbar F, Abdi S.
This study systematically reviewed the literature in order to determine the effect of ADHD on injuries and assessed the magnitude of the potential association. METHODS: A systematic review of the studies examining the association of ADH... (Source: SafetyLit)
Source: SafetyLit - June 1, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Childhood maltreatment, emotional lability, and alcohol problems in young adults at-risk for ADHD: testing moderation and moderated moderation - Bunford N, Wymbs BT, Dawson AE, Shorey RC.
Childhood maltreatment and alcohol problems are common among young adults with attention-deficit hyperactivity disorder (ADHD). However, little is known about the degree to which maltreatment and alcohol problems are associated; potential pertinent mediati... (Source: SafetyLit)
Source: SafetyLit - June 1, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Link between stress in pregnancy and ADHD unfounded
Conclusion Despite the media headlines and scaremongering, ADHD is never mentioned in the study. The researchers cite animal studies which suggest increased levels of the stress hormone cortisol may speed up development before birth. They say this may prevent proper maturation of the organs and so could cause any "mental or physical illness" occurring later in life, such as ADHD. However, for ethical reasons, the levels of stress hormones in the amniotic fluid were only measured once in this study. This means we are unable to tell whether they changed during periods of maternal stress or during the pregnancy. Tho...
Source: NHS News Feed - May 31, 2017 Category: Consumer Health News Tags: Pregnancy/child Mental health Source Type: news

Health Highlights: May 31, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Generic ADHD Drugs Approved by FDA The first generic versions of the attention-deficit/hyperactivity disorder (ADHD) drug Strattera (atomoxetine)... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 31, 2017 Category: General Medicine Source Type: news

FDA approves first generic Strattera for the treatment of ADHD
The U.S. Food and Drug Administration has approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Apotex Inc., Teva Pharmaceuticals USA Inc., Aurobindo Pharma Limited and Glenmark Pharmaceuticals Limited gained approval to market atomoxetine in multiple strengths. (Source: World Pharma News)
Source: World Pharma News - May 31, 2017 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Swiss biotech NLS Pharma's ADHD drug succeeds in mid-stage study
(Reuters) - Swiss biotech NLS Pharma AG said on Wednesday mid-stage trial data showed that its drug to treat attention deficit hyperactivity disorder (ADHD) greatly reduced symptoms in adults, paving the way for a late-stage trial. (Source: Reuters: Health)
Source: Reuters: Health - May 31, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

FDA approves first generic Strattera for the treatment of ADHD
The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. (Source: Food and Drug Administration)
Source: Food and Drug Administration - May 30, 2017 Category: American Health Source Type: news

FDA Approves First Generic Strattera for the Treatment of ADHD
May 30, 2017 -- The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients. Apotex Inc., Teva Pharmaceuticals... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 30, 2017 Category: Pharmaceuticals Source Type: news

Ritalin found to cause serious brain chemistry changes and an increase in risk-taking behaviors
(Natural News) An animal study recently published in the Journal of Neural Transmission revealed that nonprescription use of the stimulant drug Ritalin, a common treatment for attention deficit hyperactivity disorder (ADHD), was associated with increased risk-taking behaviors, sleep disruption, and other unpleasant side effects. As part of the study, a team of researchers at the University at Buffalo Research Institute on... (Source: NaturalNews.com)
Source: NaturalNews.com - May 30, 2017 Category: Consumer Health News Source Type: news

Smoking, alcohol and drug use in youth and adults with attention-deficit hyperactivity disorder - Osland S, Hirsch L, Pringsheim T.
BACKGROUND: Previous research suggests a relationship between attention-deficit hyperactivity disorder (ADHD) and smoking, alcohol and illicit drug use, however most studies have focused on adolescents or young adults, or clinically ascertained samples. AI... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Time-on-task effects in children with and without ADHD: depletion of executive resources or depletion of motivation? - Dekkers TJ, Agelink van Rentergem JA, Koole A, van den Wildenberg WPM, Popma A, Bexkens A, Stoffelsen R, Diekmann A, Huizenga HM.
Children with attention-deficit/hyperactivity disorder (ADHD) are characterized by deficits in their executive functioning and motivation. In addition, these children are characterized by a decline in performance as time-on-task increases (i.e., time-on-ta... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Attention deficit/hyperactivity disorder (ADHD) symptoms and cognitive skills of preschool children - Thomaidis L, Choleva A, Janikian M, Bertou G, Tsitsika A, Giannakopoulos G, Anagnostopoulos DC.
Attention deficit/hyperactivity disorder (ADHD) constitutes a neurobehavioral disorder which may potentially adversely affect children's wellbeing and academic achievement. The onset of symptoms is present prior to 12 years of age, and often the symptoms a... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

The behavior rating inventory of executive function and continuous performance test in preschoolers with attention deficit hyperactivity disorder - Çak HT, Cengel Kültür SE, Gökler B, Öktem F, Taşkıran C.
OBJECTIVE: The aim of this study is to examine performance-based measures and behavioral ratings of executive functions (EF) as a component of preschool attention deficit hyperactivity disorder (ADHD). METHODS: Twenty-one 4-to-6-year-old children w... (Source: SafetyLit)
Source: SafetyLit - May 29, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Adolescent ADHD Linked to Teen Parenthood Adolescent ADHD Linked to Teen Parenthood
Adolescents who have attention-deficit/hyperactivity disorder are much more likely than peers without ADHD to become teenaged parents, according to a large Danish study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 25, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Are All Those'Fidget Spinners' Really Helping Kids?
Hot toy is probably more of a distraction than a help in the classroom, experts say Source: HealthDay Related MedlinePlus Pages: Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, School Health (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - May 25, 2017 Category: Consumer Health News Source Type: news

Adolescent ADHD linked to teen parenthood
Adolescents who have attention-deficit/hyperactivity disorder are much more likely than peers without ADHD to become teenaged parents, according to a large Danish study. (Source: Reuters: Health)
Source: Reuters: Health - May 24, 2017 Category: Consumer Health News Tags: healthNews Source Type: news

Inattention and hyperactivity-impulsivity: their detrimental effect on romantic relationship maintenance - VanderDrift LE, Antshel KM, Olszewski AK.
This study involved two phases o... (Source: SafetyLit)
Source: SafetyLit - May 21, 2017 Category: International Medicine & Public Health Tags: Risk Factor Prevalence, Injury Occurrence Source Type: news

Attention-deficit hyperactivity disorder medication use: factors involved in prescribing, safety aspects and outcomes - Martinez-Raga J, Ferreros A, Knecht C, de Alvaro R, Carabal E.
While treatment of patients with attention-deficit hyperactivity disorder (ADHD) is based on a multimodal approach that combines medication with specific psychological interventions, pharmacotherapy alone is generally considered an essential and cost-effec... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Here's The Science Behind The Fidget Spinner Craze
How legitimate are claims that the fidget spinner can help with post-traumatic stress disorder, anxiety and attention deficit hyperactivity disorder? (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - May 19, 2017 Category: Pharmaceuticals Authors: Bruce Y. Lee, Contributor Source Type: news

Neural correlates of emotion reactivity and regulation in young children with ADHD symptoms - Lugo-Candelas C, Flegenheimer C, Harvey E, McDermott JM.
Emotion reactivity and regulation are frequently impaired in individuals with attention-deficit/hyperactivity disorder (ADHD), yet few studies have examined these factors in young children with ADHD, and none have explored the neural correlates of emotion ... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

Premorbid diagnosis of attention deficit hyperactivity disorder and the association of concussion risk and prolonged recovery: an evidence-based report - Horris HB, Elmer C, McLeod TCV.
Attention deficit hyperactivity disorder (ADHD) has been identified as a risk factor for concussion or delayed recovery. However, these recommendations are often based on anecdotal or limited evidence. This critically appraised topic aimed to address the c... (Source: SafetyLit)
Source: SafetyLit - May 19, 2017 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news